2/8/2008

The FDA has released a guidance that provides recommendations for manufacturers filing for Clinical Laboratory Improvement Amendments waivers for "simple" and less-hazardous in-vitro diagnostic devices. The new guidance features greater emphasis on quality-control procedures and amended study recommendations.

Full Story:
FDAnews

Related Summaries